Abstract
518MO TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have